Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
This period ended in a net loss: costs exceeded what revenue funded, so the red Loss band appears as a second source alongside Revenue. Every figure is as filed.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $12.08M | $17.11M |
| COGS | — | — |
| Gross Profit | $12.08M | $17.11M |
| R&D | $9.9M | $15.97M |
| SG&A | — | — |
| D&A | — | — |
| Other OpEx | $13.88M | $7.08M |
QuarterCharts · SEC EDGAR data · APMD · Comparing FY2026 (Q2) vs FY2025 (Q2)
| Operating Income | — | — |
| Interest Exp. | — | — |
| Other Non-Op | — | — |
| Non-Op Income | $137.82M | $309K |
| Pretax Income | $126.11M | — |
| Tax | — | — |
| Other (Below Tax) | $178K | $63.85M |
| Other Income (After Tax) | — | — |
| Tax Benefit | — | — |
| Net Income | $125.94M | — |
